Wikidata

(Q39054053)

English

Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia

scientific article published on 15 November 2013

In more languages

Statements

title
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
author name string
Santa Errichiello
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
Simona Caruso
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
Nicola Esposito
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
Maddalena Raia
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
Simona Pagliuca
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
Novella Pugliese
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
publication date
15 November 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017
page(s)
236-242
1 reference
stated in
Europe PubMed Central
PubMed ID
24280282
retrieved
8 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39054053&oldid=1854467085"